Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Expeditors International of Washington Inc.’s ( EXPD - Analyst Report ) quarterly performance lacked luster yet again. The company reported second quarter 2012 adjusted earnings of 39 cents per share that missed the Zacks Consensus Estimate of 43 cents and deteriorated 11% from 44 cents earned in the year-ago quarter. Weak revenues from air and ocean freight segments were primarily responsible for the underperformance.
Net income attributable to shareholders declined 12% year over year to $84 million in the reported quarter.
Total revenue decreased 5% year over year to $1.5 billion, and missed the Zacks Consensus Estimate of $1.6 billion. The decline in revenue was primarily due to lower shipments from air freight given poor global demand and lack of projects.
On a year-over-year basis, second quarter revenues from Other North America increased 3.3%. Revenues from the United States, Latin America, Asia Pacific, Europe and Africa, as well as Middle East and India declined 3.6%, 0.8%, 4.2%, 12.1% and 4.8%, respectively.
Quarterly gross profit (net revenue) dropped 4% year over year to $453.7 million, resulting in gross margin (yield) of 30.1%, up from 29.9% in the year-ago quarter.
Operating income declined 13% year over year to $132.4 million and operating expenses also fell 4% year over year to $1.37 billion in the reported quarter.
Revenue Segments
Airfreight Services revenue fell 14.8% year over year to $638.5 million in the second quarter.
Ocean Freight and Ocean Services revenue dropped 6.6% year over year to $519 million.
Customs Brokerage and Other Services revenues inched up 0.8% year over year to $347.4 million.
Liquidity
Expeditors’ exited the second quarter with operating cash flows of $92.8 million compared with $78.1 million at the end of the year-ago quarter. Cash and cash equivalents at the end of the second quarter was $1.4 billion, up from $1.2 billion in the same period a year ago.
Our Analysis
We remain concerned about the uncertainty over the ocean freight businesses that are likely to restrict volume growth and affect near-term profitability for Expeditors. Further, we also expect a negative impact on the company’s margins by freight rate increases by third party carriers. Additionally, competitive threats from peers like CH Robinson Worldwide Inc. ( CHRW - Analyst Report ) as well as dependence on asset-based transportation providers contribute to our negative stance on the company.
We are currently maintaining our long-term Underperform recommendation on Expeditors International. For the short-term (1-3 months) the company retains a Zacks #3 Rank (Hold).
Read the full reports :
Analyst Report on EXPD
Analyst Report on CHRW